Gastrointestinal Disease
93
5
8
45
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.1%
1 terminated out of 93 trials
97.8%
+11.3% vs benchmark
9%
8 trials in Phase 3/4
22%
10 of 45 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 45 completed trials
Clinical Trials (93)
Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?
Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases
Review of Infant Oral Feeding and Skills
Elemental 028 Extra Case Studies
Long-term Health Outcomes of Screen Detected and Potential Celiac Disease Patients
Efficacy of Guided Imagery Therapy Mobile Application for Functional Abdominal Pain
Comparison of One Anastomisis Gastric Bypass and Duodeno-Jejunostomy for Treating SMA Syndrome
Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health
Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy
Optical Imaging of Gastrointestinal Biopsy Samples and Their Correlation With Histology
Advancing Nursing Practices in Hospital Oncology Care
A Study to Evaluate Safety and Efficacy of PBK_M2502
Application of Remimazolam Combined With Esketamine in Painless Gastroscopy and Colonoscopy in Elderly Patients
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients
Therapeutic EUS Registry
Cholestasis Reversal: Efficacy of IV Fish Oil
Sedation Using Intranasal Dexmedetomidine in Upper Gastrointestinal Endoscopy
Long-term Outcomes of Duodenal Adenocarcinoma From a Large Cohort
SGM-101 in Colorectal Brain Metastases.